These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 11034589)

  • 1. Role of N-acetyltransferase polymorphisms in hepatitis B related hepatocellular carcinoma: impact of smoking on risk.
    Yu MW; Pai CI; Yang SY; Hsiao TJ; Chang HC; Lin SM; Liaw YF; Chen PJ; Chen CJ
    Gut; 2000 Nov; 47(5):703-9. PubMed ID: 11034589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of N-acetyltransferase polymorphism (NAT2) in hepatocellular carcinoma (HCC)--an investigation in a department of surgical medicine.
    Farker K; Schotte U; Scheele J; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):387-91. PubMed ID: 12877350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers.
    Yu MW; Chiu YH; Yang SY; Santella RM; Chern HD; Liaw YF; Chen CJ
    Br J Cancer; 1999 May; 80(3-4):598-603. PubMed ID: 10408872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
    Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS
    Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CYP2C19 Genotype Could be a Predictive Factor for Aggressive Manifestations of Hepatocellular Carcinoma Related with Chronic Hepatitis B Infection in Thailand.
    Nun-Anan P; Chonprasertsuk S; Siramolpiwat S; Tangaroonsanti A; Bhanthumkomol P; Pornthisarn B; Vilaichone RK
    Asian Pac J Cancer Prev; 2015; 16(8):3253-6. PubMed ID: 25921128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
    Okkels H; Sigsgaard T; Wolf H; Autrup H
    Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
    Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA
    Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of PvuII and XbaI polymorphisms in estrogen receptor alpha gene with the risk of hepatitis B virus infection in the Guangxi Zhuang population.
    Liu Y; Liu Y; Huang X; Sui J; Mo C; Wang J; Peng Q; Deng Y; Huang L; Li S; Qin X
    Infect Genet Evol; 2014 Oct; 27():69-76. PubMed ID: 25014269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer.
    Hsieh FI; Pu YS; Chern HD; Hsu LI; Chiou HY; Chen CJ
    Br J Cancer; 1999 Oct; 81(3):537-41. PubMed ID: 10507782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk.
    Bouchardy C; Mitrunen K; Wikman H; Husgafvel-Pursiainen K; Dayer P; Benhamou S; Hirvonen A
    Pharmacogenetics; 1998 Aug; 8(4):291-8. PubMed ID: 9731715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
    Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
    Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
    Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
    Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: a case-control study.
    Gelatti U; Covolo L; Talamini R; Tagger A; Barbone F; Martelli C; Cremaschini F; Franceschi S; Ribero ML; Garte S; Nardi G; Donadon V; Donato F
    Int J Cancer; 2005 Jun; 115(2):301-6. PubMed ID: 15688397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study testing the association between N-acetyltransferases 1 and 2 and risk of oral squamous cell carcinoma in Japanese people.
    Katoh T; Kaneko S; Boissy R; Watson M; Ikemura K; Bell DA
    Carcinogenesis; 1998 Oct; 19(10):1803-7. PubMed ID: 9806162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of frequencies of lifestyle factors and polymorphisms of drug-metabolizing enzymes (NAT2, CYP2E1) in human hepatocellular carcinoma (HCC) patients in a department of surgical medicine--a pilot investigation.
    Farker K; Schotte U; Scheele J; Hoffmann A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):120-4. PubMed ID: 11911601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein A1B 1267 polymorphism is highly associated with risk and prognosis of hepatocellular carcinoma: a case-control study.
    Jeng JE; Tsai JF; Chuang LY; Ho MS; Lin ZY; Hsieh MY; Chen SC; Chuang WL; Wang LY; Yu ML; Dai CY; Chang JG
    Medicine (Baltimore); 2008 Mar; 87(2):87-98. PubMed ID: 18344806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
    Cheong JY; Shin HD; Cho SW; Kim YJ
    J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL17A gene polymorphisms, serum IL-17A and IgE levels, and hepatocellular carcinoma risk in patients with chronic hepatitis B virus infection.
    Li N; Zhu Q; Li Z; Han Q; Zhang G; Chen J; Lv Y; Xing F; Chen Y; Zeng X; Liu Z
    Mol Carcinog; 2014 Jun; 53(6):447-57. PubMed ID: 23280722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Association between interleukin-18 gene polymorphisms and hepatocellular carcinoma caused by hepatitis B virus].
    Zhang QX; Yao YQ; Li SL; Long Q
    Zhonghua Gan Zang Bing Za Zhi; 2016 May; 24(5):352-7. PubMed ID: 27470888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.